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Abstract-2,3-Dihydro-lH-imidazo[l,2-blpyrazole (IMPY), a known inhibitor of DNA synthesis, has 
been shown to be a useful drug for the synchronization of mammalian cells in culture. Recent studies 
in our laboratory indicate that IMPY may possess significant antiviral activity against herpes simplex 
virus (HSV) type 1. IMPY. at a concentration of 80 pg/ml or 0.73 mM, reduced syncytia formation 
approximately 80 per cent. A 50 per cent inhibitory dose was calculated for each drug in order to 
compare potency in syncytia reduction of IMPY with that of arabinosyladenine (ara-A) and arabinosyl- 
hypoxanthine (ara-H). Our results indicated that the antiviral potencies of the three drugs were ranked 
in the order ara-A > ara-H > IMPY, the 50 per cent inhibitory doses being 22, 195 and 309 PM 
respectively. Utilizing the microplate procedure of Sidwell and Huffman [Appl. Microbial. 22, 797 
(197111, inhibition of viral cytopathic effect was rated against drug cytotoxicity and a virus rating 
(VR) established. A virus rating of 0.68 was calculated for IMPY. In comparison, VR values of 0.84 
and 0.66 were obtained for ara-A and ara-H respectively. In contrast to the syncytia reduction studies, 
IMPY appeared to possess antiviral activity equivalent to that of ara-H according to the criteria 
of the virus rating assay. A technique was developed for evaluating the degree of selectivity (‘S) of 
a drug with respect to its differential effect on viral and cellular DNA synthesis. IMPY was found 
to possess a negative selectivity at all concentrations studied, reflecting the fact that it inhibited cellular 
DNA synthesis more than viral DNA synthesis. In contrast, ara-A and ara-H both expressed positive 
degrees of selectivity in that they inhibited viral DNA synthesis more extensively than cellular DNA 
synthesis. 
The antiviral and antitumor activities of many agents 
depend, at least in part, on their ability to inhibit 
DNA synthesis. Studies in L cells have shown 
that 2,3-dihydro-lH-imidazo[l,2-blpyrazole (IMPY) 
reversibly inhibited DNA synthesis without signifi- 
cantly affecting RNA or protein synthesis [ 11. 
Although the exact mode of action of this drug is 
unknown, it was postulated that IMPY may be inter- 
fering with deoxyguanosine triphosphate synthesis. 
The inhibition of DNA synthesis seen with IMPY 
was prevented and reversed by deoxyguanosine and 
potentiated by deoxycytidine. More recently, it has 
been demonstrated that both monolayer and suspen- 
sion cultures of HeLa cells could be synchronized at 
the point of entry into the synthetic (S) phase of the 
cell cycle by IMPY [2] ; addition of deoxynucleosides, 
however, failed to reverse or prevent the inhibition 
of DNA synthesis by IMPY. It was suggested that 
this limitation may be due to the poor capacity of 
HeLa cells to phosphorylate and utilize deoxyguano- 
sine. 
The first indication that IMPY possessed antiviral 
activity appeared during studies with the nucleoside 
antibiotic 9-/?-D-arabinofuranosyladenine (ara-A), a 
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known antiviral compound [3]. IMPY was used in 
our laboratory as an agent for synchronizing suspen- 
sion cultures of KB cells. After synchronization was 
achieved, the cells were infected with herpes simplex 
virus type 1 (HSV-1) and treated with ara-A. The in- 
tracellular concentration of IMPY remaining after 
washing appeared to exert antiviral activity against 
HSV-1 even in infected cell cultures not treated with 
ara-A. 
In this paper, we describe studies of IMPY and 
its action in HSV-infected mammalian cells. Our 
studies of syncytia reduction and microplate assays 
indicate that IMPY possesses a significant antiviral 
action against HSV-1. However, biochemical studies 
involving the separation and quantitation of viral and 
cellular DNA from HSV-infected KB cells revealed 
that IMPY inhibited cellular DNA synthesis to a 
slightly greater extent than the synthesis of viral 
DNA. This lack of selectivity is in direct contrast to 
the selective inhibition of viral DNA synthesis seen 
with ara-A and its deaminated catabolite arabinosyl- 
hypoxanthine (ara-H) [4,5]. 
MATERIALS AND METHODS 
Chemicals. IMPY was generously provided by Dr. 
Herbert L. Ennis, Roche Institute of Molecular Bio- 
logy (Nutley, N.J.), and Drs. P. Schmidt and K. 
Scheibli, Ciba-Geigy Ltd. (Basel, Switzerland). Ara-A 
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was the gift of Dr. Harold E. Machamer, Parke- 
Davis, & Co. (Detroit, Mich.). Ara-H was purchased 
from Pfanstiehl Laboratories, Inc. (Waukegan, Ill.). 
[3H-methyl]thymidine was obtained from New Eng- 
land Nuclear Corp. (Boston, Mass.). HEPES 
[4-(2-hydroxyethyl)-l-piperazineethane-sulfonic acid] 
and pronase were purchased from CalBiochem (La 
Jolla, Calif.). Cesium chloride (technical grade) was 
obtained from Kawecki Berylco Industries, Inc. 
(Revere, Pa.). Sarkosyl was purchased from Geigy In- 
dustrial Chemicals (Chicago, Ill.), and thymidine from 
P-L Biochemicals, Inc. (Milwaukee, Wise.). 
Srra. Donor calf serum. free of mycoplasma and 
bacteriophage, was purchased from Flow Labora- 
tories, Inc. (Rockville, Md.). Fetal bovine serum was 
obtained from K. C. Biologicals. Inc. (Lenexa, Kan.). 
In experiments involving the use of ara-A, extensively 
heat-treated (12 hr at 56’) calf serum was used to 
prevent the serum-associated deamination of ara-A 
to ara-H 163. 
Cc/[ crrltrfre. Monolayer cultures of KB cells were 
grown at 37 in 32-07 glass prescription bottles or 
75 cm2 plastic flasks (Falcon Plastics, Oxnard, Calif.) 
in Eagle minimum essential medium with Hanks salts 
[MEM(H)] and lo”,, calf serum. 
Suspension cultures of KB cells were grown at 37- 
in 500-ml spinner flasks (Bellco Glass Co., Inc., Vine- 
land, N.J.) with 30&400 ml of minimal essential 
medium containing spinner salts [MEM(S)] 
(NaHCO, omitted) and buffered at pH 7.0 with 0.01 
M HEPES. The medium was supplemented with lo:,, 
calf serum. 
BHK-21/4 and BHK-21113 cells were grown in 
plastic flasks in MEM with Earle Salts [MEM(E)]. 
supplemented with lO”;, calf serum and 5:‘, tryptose 
phosphate broth. The sodium bicarbonate concen- 
tration was reduced to 1.85 g/liter. Incubation was 
performed at 37” in a humidified atmosphere of 97’1;, 
air and 3:‘:, COz. Virus assays and syncytia reduction 
assays were carried out with BHK-21/4 cells in Ham 
Nutrient Mixture F-12 supplemented with 5”(: fetal 
bovine serum. 
Both cell lines were passaged every 2-3 days 
according to conventional procedures using 0.05”;, 
tryps~n and 0.02”,, ethylenediaminetetraacetic acid in 
a HEPES buffered salt solution at pH 7.4 171. 
Antibiotics were not used in any cell culture media 
in order to facilitate the detection of bacterial or 
mycoplasmal contamination of the cell lines. All cell 
lines were regularly screened (tests performed by Mic- 
robiological Associates. Bethesda, Md.) and were 
found to be free of mycoplasma. 
Virus. Herpes simplex virus strain HF was the gift 
of Dr. Gary H. Cohen, Philadelphia, Pa. High titer 
virus stock was prepared according to a previously 
published method [4]. Briefly, monolayer cultures of 
KB cells were grown in MEM(H) with 104: calf serum 
and 2X arginine. The cultures were infected with virus 
at an input multiplicity of 5-10 plaque forming units 
(PFU)/cell. The cells were harvested after 24 hr and 
washed by centrifugation in fresh medium (5 min at 
300 Q). The cell pellet was resuspended and sonicdted 
for 60 set, followed by centrifugation at 500 9 for 
10 min. 
Titration of‘ Cw. Monolayer cultures of BHK-21.!4 
cells were prepared by planting 1 to 1.5 x 10” cells 
in 60 x 15 mm Contur dishes (Lux Scientific Corp., 
Thousand Oaks, Calif.) using modified MEM(E) 
medium supplemented with lo”,, calf serum. After 
incubating the dishes at 37 in a humidified 97”; air- 
3”,, CO, atmosphere overnight, the medium was 
aspirated and 0.2 ml of the appropriate viral dilution 
was added. The dishes were incubated in a CO, 
atmosphere for I hr to permit viral adsorption. 
After infection, a syncytial assay [4] was performed 
in order to determine the titer of the virus sample 
being studied. In a syncytial assay. excess virus was 
aspirated and 5 ml of F-12 medium containing lo?{, 
fetal calf serum was added to each dish and incubated 
at 37.’ in a CO* atmosphere for 2@-24 hr. After this 
interval. syncytia were counted with an inverted 
microscope (60x magnification) and the titer of the 
virus sample was calculated. 
SJwytia reduction .studirs. Syncytia reduction 
assays were performed on monolayers of HSV- 
infected BHK-2114 cells planted in 60 x 15 mm Inte- 
grid tissue culture dishes (Falcon Plastics) according 
to the procedure described above. After a 1-hr viral 
adsorption period, F-12 medium containing 0, 10, 20, 
40, 80 or 160 pg/ml of IMPY was added and allowed 
to incubate for 24 hr, after which time syncytia could 
be counted with the aid of an inverted microscope. 
A linear regression plotting program was used to 
determine the best linear relationship between per 
cent syncytia inhibition and drug concentration. 
Microrest assay. The micro tissue culture plate pro- 
cedures developed by Sidwell and Huffman [8] were 
used in our laboratory as a means of evaluating the 
antiviral activity of IMPY and other drugs. Inhibition 
of viral cytopathic ellect (CPE) was rated against drug 
cytotoxicity and a virus rating (VR) established. 
Disposable plastic microplates (Microtest II tissue 
culture plates, Falcon Plastics) containing circular 
wells were planted with BHK-21/13 cells in modified 
MEM(E). A Cornwall syringe was used to deliver 0.2 
ml of a cell suspension/well such that each well 
received approximately 3.6 x lo4 cells. After a 24-hr 
incubation at 37 in a CO*-enriched atmosphere, the 
medium was removed and each well was infected with 
0.1 ml virus suspended in MEM(E) at a concentration 
of 10 tissue culture infective dose 50 per cent 
(TCID,,)/well. 
Several min after addition of the virus suspension, 
0.1 ml medium or medium containing various concen- 
trations of the drug to be tested was added to each 
well, bringing the total volume/well to 0.2 ml. In- 
cluded in each plate were toxicity controls (containing 
drug and medium only), virus controls (containing 
virus and medium only), and cell controls (containing 
medium only). The plates were sealed with a plastic 
lid (Falcon Plastics). incubated for 3 days. and exam- 
ined microscopically for CPE and drug cytotoxicity 
every 24 hr using an inverted phase microscope. 
The condition of the cell layer in each well was 
graded on a scale of 0 (normal cells, no cytotoxicity 
or CPE) to 4 (virtually complete destruction of cell 
layer). From these data. a VR was computed for each 
drug tested. 
Prepuration Ural /trhvlir~g qf DNA. To study the 
effect of IMPY on DNA replication, tritium-labeled 
cellular and viral DNA were obtained from HSV- 
infected monolayers of KB cells by incubating each 
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monolayer in MEM(H) medium containing 
[3H-methyl]thymidine (2 &i/ml final concentration) 
for 12 hr at 37”. The medium in each flask also con- 
tained a specific concentration of IMPY (0, 10, 20, 
40. 80 and 160 pg/ml), and cold thymidine (5 PM 
concentration) to prevent the premature depletion of 
label. At the end of 12 hr the flasks were shaken 
vigorously to suspend the cells and a 5-ml sample 
was removed from each flask. The cells were pelleted 
by centrifugation at 2900 g for 15 min and the pellets 
were stored at -76’ for subsequent analysis. After 
resuspending each pellet in 0.5 ml TES [30 mM 
Tris-(hydroxymethyl)aminomethane (Tris), 5 mM 
EDTA, 50 mM NaCl, pH 8.01, an equal volume of 
a solution containing 2 mg/ml of pronase (autodi- 
gested for 15 min at 37”) and l”/i sarkosyl in TES 
was added and incubated for 15 min at 37” or until 
the mixture cleared. The preparations were rapidly 
pipetted three or four times to partially shear the 
DNA present; shearing of DNA was necessary to 
afford good separation of viral and cellular DNA in 
the CsCl density gradient. 
Ten ~1 of each DNA preparation was spotted on 
2.5-cm filter paper circles (Schleicher & Schuell, Inc., 
Keene, N.H.) which were processed as described 
below. The radioactivity contained on each filter 
paper circle was counted in a Packard liquid scintilla- 
tion spectrometer model 3320 (Packard Instrument 
Co., Downers Grove, Ill.) to determine what volume 
of the DNA preparation should be applied to each 
CsCl gradient in order to achieve satisfactory separ- 
ation. In general, 20 or 30 ~1 of the DNA preparation 
was the volume added to each gradient. 
Isoprcrric chsity gradient centr$igution. CsCl den- 
sity gradient ultracentrifugation was used to separate 
viral DNA from cellular DNA. The DNA preparation 
(2&30 ~11) was added to 9.9 g CsCl in 8.0 ml TES. 
After centrifugation at 15” using a Ti-50 rotor in a 
Beckman model L3-50 preparative ultracentrifuge, 
eight drop fractions were withdrawn from the bottom 
of the tube using a Buchler polystaltic pump and an 
LKB Ultrorac fraction collector (LKB Products, 
Bromma. Sweden). Fifty-PI samples were spotted on 
filter paper circles and processed and counted as de- 
scribed below. About forty fractions were collected 
from each tube and every fifth fraction was used to 
measure refractive index and determine buoyant den- 
sity. 
Liquid scintillation spectrometry. In order to deter- 
mine the amount of [3H]thymidine incorporated into 
DNA, 50 ~1 of each CsCl fraction was spotted in trip- 
licate on filter paper circles and processed as follows. 
The filter papers were dried rapidly under an infrared 
lamp and washed three times with ice-cold 5”/0 tri- 
chloroacetic acid, twice with 95% ethanol, and once 
with diethyl ether. The dried circles of filter paper 
were placed in vials containing 12 ml of 0.26% PPO 
(2,5-diphenyloxazole) in toluene for counting in a 
liquid scintillation spectrometer. 
RESULTS 
Inhihifion qf HSV-induced syncytia formation by 
IMPY, uru-A and ura-H. Table 1 compares and con- 
trasts the inhibitory effects of IMPY, ara-A and ara-H 
on the ability of the HF strain of herpex simplex virus 
type 1 to induce syncytia in monolayers of BHK-21/4 
cells. IMPY, at a concentration of 80 pg/ml or 0.73 
mM, reduced syncytia formation approximately 80 
per cent. In order to compare IMPY, ara-A and 
ara-H in potency of syncytia reduction, a 50 per cent 
inhibitory dose was calculated for each drug. Our 
results indicated that the antiviral potencies of the 
three drugs were ranked in the order ara-A > ara- 
H > IMPY, the 50 per cent inhibitory doses being 
22. 195 and 309 PM respectively. 
Determinution of virus rating. Utilizing the micro- 
plate procedure of Sidwell and Huffman [8] a virus 
rating (VR) was calculated for IMPY, ara-A and 
ara-H. A summary of the results is listed in Table 
2. In contrast to the syncytia reduction studies, the 
three drugs were rated in the order ara-A > IMPY 
= ara-H, on the basis of the VR that each received 
(0.84, 0.68 and 0.66 respectively). Thus, IMPY 
appeared to possess antiviral activity equivalent to 
that of ara-H according to the criteria set forth in 
the studies of Sidwell and Huffman [8]. In addition, 
IMPY showed less cytotoxicity than ara-A and ap- 
proximately the same cytotoxicity as ara-H on a per 
mole basis. 
Inhibition qf’ ce/lulur und virul DNA synthesis in 
HSV-infected KB cells. DNA synthesized in HSV- 
infected monolayer cultures of KB cells during a 
12-hr exposure to C3H]thymidine was separated into 
viral and cellular components in CsCl density gra- 
dients. Each species of DNA was separated on the 
basis of its buoyant density, owing to the different 
G + C ratios of HSV DNA and KB cell DNA. Typi- 
cal profiles of radioactivity in fractions from CsCl 
Table 1. Effect of IMPY, ara-A and ara-H on syncytia formation in HSV-infected BHK-21/4 cells* 
Drug 
Per cent reduction of HSV-induced syncytia forming units when 
compared to control cultures (no drug) 
Concentration of drug (m/ml) 
0.1 1 2 5 10 20 40 80 160 
IMPY 14 f 21t 50 k 23 55 * 4 80 4 + 78 + 15 
Ara-A$ 20 26 29 40 71 97 99 >99 100 
Ara-Hz 4 2 35 65 85 
*Two hundred syncytium forming units (SFU) of herpes simplex virus were added to nearly confluent monolayers 
of BHK-2114 cells in 60 x 15 Integrid plastic dishes. Adsorption was allowed to occur at 37“ for 1 hr, after which 
time 5 ml of Ham’s Nutrient Mixture F-12 medium supplemented with ST,;, fetal bovine serum and the appropriate 
drug concentration was added. Syncytia were counted after a 20-hr incubation. 
t All values are + the standard error of the mean, 
$ Data were obt&ed from previous studies in our laboratory [4]. 
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Table 2. Microtest screen of IMPY. ara-A and ara-H on BHK-21.13 cells infected with 
HSV-1 (IO TCID,,/well)* 
Drug 
Concentrations used in test wells? 
(/lgml) Virus rating at 72 hr 
IMPY 0. 3.2, IO. 32. 100 and 320 0.68 k 0.01: 
Ara-A 0, 3.2. 10. 32. 100 and 320 0.84 ) 0.01 
Ara-H 0, 10, 32. 100. 320 and 1000 0.66 + 0.02 
* Monolayers of BHK-21113 cells. grown in micro tissue culture plates. were infected with 
HSV-I (10 TCID,,, /well) and incubated with the appropriate drug concentration at 37 in 
a humidified CO* atmosphere for 72 hr. The virus rating for each drug was calculated 
according to the methods of Sidwell and Huffman [Xl. 
t In all cases, concentrations were selected which ranged from completely inactive to totally 
cytotoxic. 
1 All values are + the standard error of the mean. 
density gradients are shown in Fig. I. Presumably 
because a technical grade of CsCl was used to prepare 
the gradients, buoyant densities slightly less than the 
expected values were obtained. 
Viral and cellular DNA synthesis in drug-treated 
cultures was compared to the viral and cellular DNA 
synthesized in the virus-infected cultures without 
drug. The radioactivity associated with viral and 
cellular DNA was determined by summing the cpm 
in the fractions which composed each peak in Fig. 
1. The ratio of viral DNA to cellular DNA was calcu- 
lated and used to proportion the total DNA synthe- 
sized in the infected cells into the viral and cellular 
components. Data from drug-treated cultures were 
normalized to data from the control culture. The per 
cent reduction of viral and cellular DNA synthesized 
at each drug level was then computed with respect 
to the control cultures containing no drug (Fig. 2). 
This figure illustrates that, in infected monolayer cul- 
tures, IMPY inhibited cellular DNA synthesis to a 
greater extent than viral DNA synthesis at all drug 
levels studied. 
The results shown in Fig. 2 were used to determine 
the degree of selectivity (S) shown by IMPY and 
that of ara-A and ara-H in reducing viral and cellular 
DNA synthesis. The equation below allows the calcu- 
lation of a value which expresses the positive or nega- 
tive selectivity of a drug in its action on DNA syn- 
thesis in virus-infected cell cultures: 
CIC’ 
‘S, = log,, ~ F 1 V/V’ ’ 
where C is equal to the total number of cpm/cell con- 
tained within the CsCl gradient peak representing 
cellular DNA synthesized when drug is present at 
concentration n. C’ is equal to the total number of 
cpm/cell contained within the CsCl gradient peak 
representing cellular DNA synthesized when no drug 
was present. V is the total number of cpm/cell con- 
tained in the CsCl gradient peak representing viral 
DNA synthesized when drug was present at concen- 
tration n. T/’ is equal to the total number of cpm,/cell 
contained within the CsCl gradient peak representing 
viral DNA synthesized in the control cultures when 
no drug was present. 
The results of a selectivity analysis of IMPY, ara-A 
and ara-H are illustrated in Fig. 3. Positive values 
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Fig. I. Separation by isopycnic centrifugation in CsCl den- 
sity gradients of viral and cellular DNA synthesized in 
HSV-infected monolayer cultures of KB cells. Location of 
viral and cellular DNA in the gradients was monitored 
by C3H]thymidine incorporation. Cultures contained no 
drug or IO. 20, 40. 80 or 160 jfg!ml of IMPY 
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Fig. 2. Effect of IMPY on the reduction of viral and cellu- 
lar DNA synthesis in monolayer cultures of KB cells. The 
total cpm contained within each peak of viral or cellular 
DNA was computed from Fig. 1 and corrected for vari- 
ation in cell number. 
thesis to a greater extent than cellular DNA synthesis 
at the concentration indicated. whereas negative ‘S 
values reflect more extensive inhibition of cellular 
than viral DNA synthesis. IMPY was found to pos- 
sess negative selectivity at all concentrations studied. 
In contrast, am-A and ara-H both express positive 
selectivity. 
Fig. 3. Degree of selectivity (“S) at drug concentration n 
of IMPY, ara-A and ara-H in HSV-infected monolayer 
cultures of KB cells. C is equal to the total number of 
cpmjcell contained within the CsCl gradient peak repre- 
senting cellular DNA synthesized when drug is present at 
concentration n. c’ is equal to the total number of cpm/cell 
contained within the CsCl gradient peak representing 
cellular DNA synthesized when no drug was present. V 
is the total number of cpm/cell contained in the CsCl gra- 
dient peak representing viral DNA synthesized when drug 
was present at concentration n. v’ is equal to the total 
number of cpm/cell contained within the CsCl gradient 
peak representing viral DNA synthesized when no drug 
was present. A positive value of ‘S indicates that the inhibi- 
tion of viral DNA synthesis is greater than cellular DNA 
synthesis at the dose under consideration. When a drug 
concentration results in cellular DNA synthesis being inhi- 
bited more extensively than viral DNA synthesis, a nega- 
DISCCSSION tive value of ‘S results. 
The antiviral activity of IMPY was assessed in 
mammalian cell cultures infected with herpes simplex 
virus type 1. Our results indicated that IMPY exerted 
an antiviral action on HSV-1 in syncytia reduction 
studies and microplate tissue culture assays but 
further biochemical studies demonstrated that the in- 
hibitory effects of IMPY were not directed solely 
toward viral infection. Determination of the drug’s 
effect on viral and cellular DNA synthesis indicated 
that IMPY reduced cellular DNA synthesis to a 
greater extent than viral DNA synthesis at all drug 
levels studied. 
We have attempted to evaluated the degree of selec- 
tivity (S) of a drug with respect to its differential 
effect on viral and cellular DNA synthesis, A drug 
was assigned a positive ~‘S if it acted to reduce viral 
DNA synthesis to a greater extent than cellular DNA 
synthesis. Conversely, a drug which inhibited cellular 
DNA synthesis more than viral DNA synthesis was 
designated as being negatively selective. Although this 
index of selectivity has proved useful in our studies 
comparing the antiviral activities of various drugs, 
our definition of S possesses several limitations 
which should be considered. 
tory effect of a viral infection on the cellular DNA 
synthetic process. Depending on the multiplicity of 
viral infection, the initiation of viral DNA synthesis 
with its inherent domination of the cellular DNA syn- 
thetic machinery may affect the total amount of cellu- 
lar DNA produced. Thus, by not incorporating the 
total amount of cellular DNA synthesized in the unin- 
fected cell into our concept of degree of selectivity, 
we may be introducing an error into our evaluation. 
Further selectivity studies of various drugs have been 
performed in our laboratory involving both virus- 
infected and uninfected cell cultures. A modified, 
dose-independent definition of “S has been formulated 
and will be presented at a future time [9]. 
On the basis of the criteria discussed above, our 
results indicated that IMPY possessed a negative 
value of ‘S in HSV-infected mammalian cells at all 
drug levels studied. The reason for this negatively 
selective action is unknown at the present time. 
IMPY may act by exerting a differential inhibition 
of a cellular enzyme as opposed to its viral-induced 
enzyme counterpart in the infected cell. 
The primary limitation of degree of selectivity as 
we have defined it resides in the fact that each value 
of ‘S is dose dependent. As a result, as the denomi- 
nator of the equation approaches zero, ‘S becomes 
artificially high, and this exaggeration must be taken 
into account when interpreting the data. 
Our definition of S evaluates viral and cellular 
DNA synthesis in virus-infected cell cultures only. 
This application does not consider the general inhibi- 
In contrast to IMPY, ara-A and ara-H were found 
to exhibit different degrees of positive selectivity, ref- 
lecting the fact that both drugs inhibit viral DNA 
synthesis more than cellular DNA synthesis, Previous 
studies in our laboratory suggest that the selective 
inhibition of viral DNA synthesis by ara-A and ara-H 
may be due to the preferential inhibition of a step 
in nucleotide metabolism catalyzed by a virus-speci- 
fied enzyme [4,5]. 
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The results presented in this paper do not offer 
any definitive explanation for the mechanism of 
action of IMPY. Previously, Ennis et ul. [l] suggested 
that IMPY inhibited DNA synthesis by interfering 
with deoxyguanosine triphosphate synthesis. They 
observed that the inhibition of DNA synthesis seen 
with IMPY was prevented and reversed by deoxy- 
guanosine and potentiated by deoxycytidine in L 
cells [l]. In contrast to these studies, Beer et ul. [2] 
demonstrated that addition of deoxynucleosides failed 
to reverse or prevent the inhibition of DNA synthesis 
by IMPY in HeLa cells. Further experimentation 
with regard to the effect of IMPY on cellular and 
viral metabolism and enzyme action is warranted. 
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